MYC and cancer: These studies support the use of MB/D-MBs and UTMD as a novel systemic delivery modality to deliver viruses (such as Ad.mda-7/CTV) to internal tumors (such as prostate tumors in Hi-Myc mice), resulting in profound anti-cancer activity.